On June 6, Argenx SE rose 6.11% in regular trading, trading at $891.95/share, with trading volume of $391 million.
Within the Biotechnology sector where Argenx SE belongs, the overall sector showed broad gains. Among individual stocks, BioCardia up 35.47%, Amgen up 2.46%, AbbVie up 1.91%, Vertex Pharmaceuticals up 1.64%, Gilead Sciences up 1.19%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)